ABT Stock-Based Compensation

Abbott Laboratories · Stock-Based Compensation

ABT logo

ABT Stock-Based Compensation

Latest reported$718.00M
ABT TTM Stock-Based Comp ($0.00 → $718.00M)
High-resolution chart · PNG

ABT stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Abbott Laboratories Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
718,000,000
692,000,000
664,000,000
662,000,000
659,000,000
658,000,000
673,000,000
676,000,000
676,000,000
667,000,000
644,000,000
645,000,000
651,000,000
661,000,000
685,000,000
676,000,000
667,000,000
657,000,000
640,000,000
632,000,000
618,000,000
601,000,000
546,000,000
533,000,000
527,000,000
526,000,000
519,000,000
515,000,000
504,000,000
491,000,000
477,000,000
464,000,000
456,000,000
447,000,000
406,000,000
385,000,000
359,000,000
329,000,000
310,000,000
306,000,000
301,000,000
296,000,000
292,000,000
287,000,000
283,000,000
275,000,000
246,000,000
247,948,000
252,948,000
254,948,000
261,948,000
296,379,000
326,987,000
361,772,000
433,114,000
421,234,000
413,464,000
404,136,000
382,602,000
377,050,000
381,358,000
389,125,000
387,183,000
389,095,000
379,536,000
353,276,000
366,357,000
654,513,000
591,926,000
601,833,000
566,808,000
266,123,000
266,123,000
198,252,000
200,031,000
290,175,000
290,175,000
290,175,000
136,474,000
9,745,000
9,704,000
9,704,000
9,704,000
-10,261,000
-10,220,000
-10,220,000
-10,220,000
-7,657,000
-7,657,000
-7,657,000
-7,657,000
11,719,000
11,719,000
11,719,000
11,719,000
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.